Landry K. Kamdem - Concepedia

Author

Landry K. Kamdem

Johannes Gutenberg University Mainz ORCID

Also Known As

Kamdem, Landry, L K Kamdem, L Kamdem, L. K. Kamdem, L. Kamdem, Landry K Kamdem, Landry K. Kamdem, Landry Kamdem, Landry Kamdem Kamdem, LandryK. Kamdem

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz University of Göttingen Harding University Main Campus Indiana University – Purdue University Indianapolis St. Jude Children's Research Hospital

About

Landry K. Kamdem is an author at Johannes Gutenberg University Mainz specializing in medicine, pharmacology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	251
2	Health Sciences	2	2	34
3	Biochemistry	2	2	168
4	Natural Sciences	1	1	149
5	Public Health	1	1	49

Landry K. Kamdem

Publications

888

Citations

H-Index

Page 1

	Year	Citations
Contribution of CYP3A5 to the in Vitro Hepatic Clearance of Tacrolimus Landry K. Kamdem, Frank Streit, Ulrich M. Zanger, Clinical Chemistry	2005	219
Dominant Contribution of P450 3A4 to the Hepatic Carcinogenic Activation of Aflatoxin B<sub>1</sub> Landry K. Kamdem, Ingolf Meineke, Ute Gödtel‐Armbrust, Chemical Research in Toxicology Metabolomic ProfilingPathologyRedox BiologyToxicological MechanismHepatic Carcinogenic Activation	2006	149
Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age Zeruesenay Desta, Yvonne Kreutz, Anne Nguyen, Clinical Pharmacology & Therapeutics	2011	107
A mouse model for glucocorticoid‐induced osteonecrosis: Effect of a steroid holiday Lei Yang, Kelli L. Boyd, Sue C. Kaste, Journal of Orthopaedic Research®	2008	99
<i>In vitro</i> and <i>in vivo</i> oxidative metabolism and glucuronidation of anastrozole Landry K. Kamdem, Yong Liu, Vered Stearns, British Journal of Clinical Pharmacology	2010	79
In Vitro Cytochrome P450-Mediated Metabolism of Exemestane Landry K. Kamdem, David A. Flockhart, Zeruesenay Desta Drug Metabolism and Disposition	2010	73
Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populations Markus Schirmer, Mohammad R. Toliat, Michael Haberl, Pharmacogenetics and Genomics Phenotypic VariationVitamin D MetabolismGeneticsGenetic EpidemiologyHuman Polymorphism	2006	49
Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia Landry K. Kamdem, Leo H. Hamilton, Cheng Cheng, Pharmacogenetics and Genomics	2008	45
Limited contribution of CYP3A5 to the hepatic 6?-hydroxylation of testosterone Landry K. Kamdem, Ingolf Meineke, Ina Koch, Naunyn-Schmiedeberg s Archives of Pharmacology SpermatogenesisLimited ContributionHepatologyEndocrine MechanismMedicine	2004	19
Impact of<i>UGT2B17</i>Gene Deletion on the Pharmacokinetics of 17-Hydroexemestane in Healthy Volunteers Shanly M. Chen, Daniel H. Atchley, Michael A. Murphy, The Journal of Clinical Pharmacology Breast OncologyPharmacotherapyPre-clinical PharmacologyMolecular PharmacologyPharmacogenomics	2015	19

Page 1